What GHK-Cu is
GHK-Cu is a naturally occurring tripeptide consisting of three amino acids: glycine, histidine, and lysine. The "Cu" refers to copper, specifically the cupric ion (Cu2+) that GHK binds with high affinity. The human body produces this compound naturally; it is found in plasma, saliva, and urine, and plasma concentrations decline with age.
The peptide was first isolated from human plasma in 1973 by Loren Pickart, who observed that it had a stimulatory effect on liver cell growth in culture. Subsequent decades of research expanded the picture: GHK and its copper complex appear to activate genes involved in tissue repair, skin remodeling, antioxidant defense, and collagen and elastin production. That biological activity underpins its use in skincare, where it has been formulated as an active cosmetic ingredient for well over 30 years.
Topical GHK-Cu is a cosmetic. Injectable GHK-Cu is a research compound. These are different things.
When GHK-Cu appears as an ingredient in a serum, cream, or scalp treatment, it is regulated by the FDA as a cosmetic ingredient. The brand selling it does not need FDA approval, but the product must comply with cosmetics regulations, cannot make drug claims, and is subject to standard consumer safety rules. This is a legal, mainstream category of commerce.
When GHK-Cu is sold as a lyophilized powder or solution for injection, it is sold as a research compound. This use is not FDA-approved. The compound has not gone through the Investigational New Drug or New Drug Application process for any injectable indication. Research-labeled GHK-Cu is not cleared for human administration. The evidence base for injectable use is substantially thinner than for topical use, and the quality control standards applying to research-grade compounds are far less rigorous than those for pharmaceutical drugs or even regulated cosmetics.
This distinction matters enormously for how you evaluate any claim about GHK-Cu. A skincare brand citing studies on collagen synthesis to support its topical serum is operating in a space where that evidence is at least directionally relevant. A research vendor citing the same topical studies to imply systemic benefits from injection is making a much larger inferential leap, one that the current evidence does not support.
How GHK-Cu is discussed and used
GHK-Cu appears in two distinct commercial contexts: cosmetic skincare products and injectable research compounds. The claims and the evidence look quite different depending on which you are examining.
Skin aging and collagen support
Multiple published studies show topical GHK-Cu can stimulate collagen and elastin synthesis, reduce the appearance of fine lines, and improve skin thickness. A double-blind clinical study found improvements in skin laxity and density. This is the best-supported application of GHK-Cu across the scientific literature.
Limited but positive human dataWound healing
GHK-Cu has a documented history in wound care research. Studies show it can accelerate wound contraction, increase production of proteins involved in skin repair, and support angiogenesis. Some formulations have been studied in clinical wound care contexts. The evidence here is stronger than for most claims in the peptide space.
Established in wound researchHair follicle stimulation
Small studies and in vitro work suggest GHK-Cu may stimulate hair follicle size and growth signaling. Some scalp products include it on this basis. The evidence is preliminary: no large controlled clinical trials on GHK-Cu for hair loss have been published. Promising in early research but not established.
Early-stage / preliminarySystemic anti-aging and tissue repair
Research vendors and online communities discuss injectable GHK-Cu for systemic tissue repair, anti-aging, and recovery. The in vitro evidence showing gene activation is real; the leap to meaningful systemic human outcomes from injection is not backed by controlled trials. The mechanism is interesting; the clinical evidence does not yet exist.
Preclinical onlyThe pattern here is that the topical evidence is real and reasonably developed, particularly for skin aging and wound healing. The injectable evidence is largely inferred from that topical and in vitro research, with almost no direct human clinical data on what injectable GHK-Cu actually does at what doses and over what time periods.
How to evaluate a vendor selling GHK-Cu
The vendor evaluation process for GHK-Cu depends almost entirely on which category you are shopping in. Buying a cosmetic GHK-Cu serum from a skincare brand involves different considerations than evaluating a research-grade injectable supplier.
Vendor evaluation checklist
- Identify the category first: Is this a topical cosmetic product or an injectable research compound? The answer changes every other evaluation criterion. Cosmetic products should carry standard labeling, ingredient lists, and brand accountability. Research compounds require a different level of scrutiny.
- Third-party COA from an accredited lab (research vendors): For research-grade GHK-Cu, the certificate of analysis should come from an independent laboratory with ISO 17025 accreditation or equivalent. The lab's name, accreditation number, and contact information should be verifiable.
- Batch traceability: The COA should reference the specific batch number matching what you are buying. An undated or non-batch-specific COA offers minimal quality assurance about what is actually in the vial.
- Purity and identity testing: Look for HPLC purity data above 98% combined with mass spectrometry confirming the compound's identity. Single-method testing is a weaker standard.
- Claims review: A research vendor making treatment or outcome claims for injectable GHK-Cu is operating outside what the evidence supports and outside the legal scope of research compound marketing. Vendors with aggressive outcome claims deserve more scrutiny, not more trust.
- Sterility for injectable compounds: Research-grade GHK-Cu is not manufactured under pharmaceutical-grade sterility requirements. Sterility testing documentation, if available, is a positive sign. Its absence is not unusual but worth noting.
- Cosmetic brands: For topical products, look for established brands with transparent ingredient sourcing and concentrations. GHK-Cu is typically used at 1-4% in formulations; undisclosed concentrations make it harder to compare with published research.
Affiliate disclosure: The link below is a paid affiliate relationship. We earn a commission if you purchase through it. This relationship did not influence our evaluation of GHK-Cu or the vendor criteria above. See our full disclosure policy.
Looking for a research vendor that meets these criteria?
We reviewed research-grade GHK-Cu vendors against the checklist above. The following link goes to a vendor whose COA documentation and batch traceability we found consistent with the standards described in this article. This is a research compound. We have not evaluated the product itself, and this is not a clinical recommendation. GHK-Cu sold by this vendor is intended for research purposes only and is not cleared for human use.
View vendor COA documentation Affiliate linkRelated compounds and further reading
GHK-Cu is sometimes grouped with tissue-repair peptides or discussed alongside anti-aging compounds. A few related areas worth understanding:
Sources
- 1 Pickart L, Vasquez-Soltero JM, Margolina A. GHK peptide as a natural modulator of multiple cellular pathways in skin regeneration. Biomed Res Int. 2015;2015:648108. PubMed
- 2 Finkley MB, Appa Y, Bhandarkar S. Copper peptide and skin. Cosmeceuticals and Active Cosmetics: Drugs vs. Cosmetics. 2005;2:549-563. Available through dermatology literature databases.
- 3 Pickart L, Margolina A. Regenerative and protective actions of the GHK-Cu peptide in the light of the new gene data. Int J Mol Sci. 2018;19(7):1987. PubMed
- 4 Abdulghani AA, et al. Peptides in skin rejuvenation. J Drugs Dermatol. 2009;8(5):441-443. PubMed
- 5 Zheng Z, et al. Hair growth promoting effects of GHK-Cu on human hair follicles. Int J Mol Sci. 2022;23(4):2183. PubMed
- 6 FDA. Cosmetics overview: FDA regulation of cosmetics. FDA.gov
- 7 FDA. Research use only products. Guidance on IND requirements and unapproved compounds. FDA.gov
